4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001415889-25-019242
Director sold 20,925 shares at an average $23.57 ($493,191)
- Director acquired 20,925 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS Director | 2025-07-02 | Option exercise 10b5-1 | +20,925 | $6.93 | $145,010 | 25,890 | D |
| RENTON HOLLINGS Director | 2025-07-02 | Sale 10b5-1 | −7,250 | $23.09 | $167,408 | 18,640 | D |
| RENTON HOLLINGS Director | 2025-07-02 | Sale 10b5-1 | −13,675 | $23.82 | $325,782 | 4,965 | D |
| Derivatives | |||||||
| RENTON HOLLINGS Director | 2025-07-02 | Option exercise · Common Stock 10b5-1 | −20,925 | 0 | D | ||
| Open-market sales · 20,925 sh · avg $23.57 · $493,191 | |||||||
Loading xslF345X05/form4-07032025_050730.xml…